If you need more lookups,
subscriptions start at $34 USD/month.
Jérôme Respaud Location
Toulouse, Occitanie, FR
Jérôme Respaud Work
Pharmaceutical Development and Control Department Director and global sites harmonization @ (November 2018 - Present)
Site Manager @ Amatsigroup, site Fontenilles (January 2017 - October 2018)
Head of Pharmaceutical and Bioanalysis department @ Amatsigroup (site AmatsiAvogadro) (February 2015 - December 2016)
Head of Pharmaceutical Analysis department @ (January 2013 - February 2015)
Manager Quality Control @ Avogadro (February 2009 - December 2012)
Project Leader in analytical chemistry @ Avogadro (October 2005 - February 2009)
Ingénieur en Recherche et Développement et Responsable Analytique du laboratoire @ Genibio recherche (groupe Larena, 3i nature) (October 2001 - September 2005)
Jérôme Respaud Education
Ecole Nationale Supérieure des Ingénieurs en Arts Chimiques et Technologiques
Diplôme d'ingénieur (Chimie analytique)
1998-2021
La Prépa des INP
1998 (Chimie analytique)
1996-1998
Jérôme Respaud Skills
Analytical Chemistry
BPF
Chimie analytique
Contrôle qualité
GMP
HPLC
Pharmaceutical Industry
Pharmaceutics
Pharmaceutique
Quality Control
Sciences de la vie
Secteur pharmaceutique
Validation
Gestion de projet
Microsoft Excel
Analysis
Project Planning
Sales
Jérôme Respaud Summary
Jérôme Respaud, based in Toulouse, Occitanie, FR, is currently a Pharmaceutical Development and Control Department Director and global sites harmonization at CEBIPHAR. Jérôme Respaud brings experience from previous roles at Amatsigroup, site Fontenilles, Amatsigroup (site AmatsiAvogadro), Amatsi Group (site Amatsi Avogadro) and Avogadro. Jérôme Respaud holds a 1998 - 2021 Diplôme d'ingénieur in Chimie analytique @ Ecole Nationale Supérieure des Ingénieurs en Arts Chimiques et Technologiques. With a robust skill set that includes Analytical Chemistry, BPF, Chimie analytique, Contrôle qualité, GMP and more. Jérôme Respaud has 2 emails on RocketReach.
Looking for a different Jérôme Respaud?
Find contact details for 700 million professionals.